Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.

Also called NCT07441382

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07441382
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07441382. Randomized; no masking; primary purpose treatment. Start 2026-03-24 (actual); primary completion 2027-05-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation
Acronym
CLEAR-AF
Condition
Atrial Fibrillation (AF)
Condition
Stroke
Condition
Hemorrhage
Condition
Frailty
Condition
Atrial Appendage
Condition
Anticoagulants
Intervention (Device)
catheter ablation combined with LAAO (Left Atrial Appendage Occlusion)
Intervention (Drug)
Atrial Fibrillation Radiofrequency Ablation Only
Lead sponsor
Guangdong Provincial People's Hospital (class: other)
Collaborator
Abbott (China) (class: industry)

Record details

Record id
cardio:ct-nct07441382
Content hash
5a2f0be3e6177d41444bc6d9bfa767853d7c3c89549b470b928035e9e49aa70b